Search Results - "Kranjac, Carlene A"
-
1
AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer
Published in BMC cancer (23-04-2022)“…The receptor tyrosine kinase (RTK) epidermal growth factor receptor (EGFR) is overexpressed and an important therapeutic target in Head and Neck cancer (HNC)…”
Get full text
Journal Article -
2
MerTK Drives Proliferation and Metastatic Potential in Triple-Negative Breast Cancer
Published in International journal of molecular sciences (01-05-2024)“…Triple-negative breast cancer (TNBC) is characterized by the absence of the estrogen receptor, progesterone receptor, and receptor tyrosine kinase HER2…”
Get full text
Journal Article -
3
AXL Mediates Cetuximab and Radiation Resistance Through Tyrosine 821 and the c-ABL Kinase Pathway in Head and Neck Cancer
Published in Clinical cancer research (15-08-2020)“…Radiation and cetuximab are therapeutics used in management of head and neck squamous cell carcinoma (HNSCC). Despite clinical success with these modalities,…”
Get full text
Journal Article -
4
Abstract 1334: MerTK tumorigenesis and immune evasion mechanisms in triple negative breast cancer
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract Triple negative breast cancer (TNBC) cells lack estrogen, progesterone, and HER2 receptors. TNBC tends to be more aggressive than most types of breast…”
Get full text
Journal Article -
5
Abstract 6994: MerTK drives proliferation and metastasis activity in triple negative breast cancer
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Abstract Triple negative breast cancer (TNBC) is characterized by the absence of estrogen, progesterone, and HER2 receptors. It exhibits a higher level of…”
Get full text
Journal Article